John Libbey Eurotext

European Cytokine Network

BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines Volume 9, numéro 2, June 1998

Illustrations

Ouvrir l'onglet

INTRODUCTION Intravesical BCG therapy has been successfully used for the treatment of superficial bladder cancer [1, 2]. For BCG therapy to be effective, the development of an immune response seems to be important, although the exact mechanism remains to be established [3]. For the initiation of the immune reaction, several steps during the first interaction of BCG with the bladder wall have been suggested to be involved....